209 related articles for article (PubMed ID: 15728834)
1. Antiepileptic effects of botulinum neurotoxin E.
Costantin L; Bozzi Y; Richichi C; Viegi A; Antonucci F; Funicello M; Gobbi M; Mennini T; Rossetto O; Montecucco C; Maffei L; Vezzani A; Caleo M
J Neurosci; 2005 Feb; 25(8):1943-51. PubMed ID: 15728834
[TBL] [Abstract][Full Text] [Related]
2. Proconvulsant actions of intrahippocampal botulinum neurotoxin B in the rat.
Bröer S; Zolkowska D; Gernert M; Rogawski MA
Neuroscience; 2013 Nov; 252():253-61. PubMed ID: 23906638
[TBL] [Abstract][Full Text] [Related]
3. Acute neuroprotection by the synaptic blocker botulinum neurotoxin E in a rat model of focal cerebral ischaemia.
Antonucci F; Cerri C; Maya Vetencourt JF; Caleo M
Neuroscience; 2010 Aug; 169(1):395-401. PubMed ID: 20447449
[TBL] [Abstract][Full Text] [Related]
4. Evidence for anterograde transport and transcytosis of botulinum neurotoxin A (BoNT/A).
Restani L; Antonucci F; Gianfranceschi L; Rossi C; Rossetto O; Caleo M
J Neurosci; 2011 Nov; 31(44):15650-9. PubMed ID: 22049408
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of neurotransmitter release by peptides that mimic the N-terminal domain of SNAP-25.
Apland JP; Adler M; Oyler GA
J Protein Chem; 2003 Feb; 22(2):147-53. PubMed ID: 12760419
[TBL] [Abstract][Full Text] [Related]
6. Botulinum neurotoxin E (BoNT/E) reduces CA1 neuron loss and granule cell dispersion, with no effects on chronic seizures, in a mouse model of temporal lobe epilepsy.
Antonucci F; Di Garbo A; Novelli E; Manno I; Sartucci F; Bozzi Y; Caleo M
Exp Neurol; 2008 Apr; 210(2):388-401. PubMed ID: 18177862
[TBL] [Abstract][Full Text] [Related]
7. Intrahippocampal infusion of botulinum neurotoxin E (BoNT/E) reduces spontaneous recurrent seizures in a mouse model of mesial temporal lobe epilepsy.
Antonucci F; Bozzi Y; Caleo M
Epilepsia; 2009 Apr; 50(4):963-6. PubMed ID: 19175393
[TBL] [Abstract][Full Text] [Related]
8. Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle.
Adler M; Keller JE; Sheridan RE; Deshpande SS
Toxicon; 2001; 39(2-3):233-43. PubMed ID: 10978741
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
Sharma SK; Singh BR
Biochemistry; 2004 Apr; 43(16):4791-8. PubMed ID: 15096048
[TBL] [Abstract][Full Text] [Related]
10. Uptake of botulinum neurotoxin into cultured neurons.
Keller JE; Cai F; Neale EA
Biochemistry; 2004 Jan; 43(2):526-32. PubMed ID: 14717608
[TBL] [Abstract][Full Text] [Related]
11. BoNT/E prevents seizure-induced activation of caspase 3 in the rat hippocampus.
Manno I; Antonucci F; Caleo M; Bozzi Y
Neuroreport; 2007 Mar; 18(4):373-6. PubMed ID: 17441289
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effectiveness of botulinum neurotoxin A: potent blockade of autonomic transmission by targeted cleavage of only the pertinent SNAP-25.
Lawrence GW; Ovsepian SV; Wang J; Aoki KR; Dolly JO
Neuropharmacology; 2013 Jul; 70():287-95. PubMed ID: 23485402
[TBL] [Abstract][Full Text] [Related]
13. BoNT/E prevents seizure-induced activation of caspase 3 in the rat hippocampus.
Manno I; Antonucci F; Caleo M; Bozzi Y
Neuroreport; 2007 Apr; 18(6):577-80. PubMed ID: 17413660
[TBL] [Abstract][Full Text] [Related]
14. Distinct exocytotic responses of intact and permeabilised chromaffin cells after cleavage of the 25-kDa synaptosomal-associated protein (SNAP-25) or synaptobrevin by botulinum toxin A or B.
Lawrence GW; Foran P; Dolly JO
Eur J Biochem; 1996 Mar; 236(3):877-86. PubMed ID: 8665909
[TBL] [Abstract][Full Text] [Related]
15. Importance of two adjacent C-terminal sequences of SNAP-25 in exocytosis from intact and permeabilized chromaffin cells revealed by inhibition with botulinum neurotoxins A and E.
Lawrence GW; Foran P; Mohammed N; DasGupta BR; Dolly JO
Biochemistry; 1997 Mar; 36(11):3061-7. PubMed ID: 9115981
[TBL] [Abstract][Full Text] [Related]
16. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.
Blasi J; Chapman ER; Link E; Binz T; Yamasaki S; De Camilli P; Südhof TC; Niemann H; Jahn R
Nature; 1993 Sep; 365(6442):160-3. PubMed ID: 8103915
[TBL] [Abstract][Full Text] [Related]
17. Long-lasting attenuation of amygdala-kindled seizures after convection-enhanced delivery of botulinum neurotoxins a and B into the amygdala in rats.
Gasior M; Tang R; Rogawski MA
J Pharmacol Exp Ther; 2013 Sep; 346(3):528-34. PubMed ID: 23772062
[TBL] [Abstract][Full Text] [Related]
18. The role of the synaptic protein snap-25 in the potency of botulinum neurotoxin type A.
Keller JE; Neale EA
J Biol Chem; 2001 Apr; 276(16):13476-82. PubMed ID: 11278807
[TBL] [Abstract][Full Text] [Related]
19. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage.
Vaidyanathan VV; Yoshino K; Jahnz M; Dörries C; Bade S; Nauenburg S; Niemann H; Binz T
J Neurochem; 1999 Jan; 72(1):327-37. PubMed ID: 9886085
[TBL] [Abstract][Full Text] [Related]
20. Increased susceptibility to hippocampal and amygdala kindling following intrahippocampal kainic acid.
Feldblum S; Ackermann RF
Exp Neurol; 1987 Aug; 97(2):255-69. PubMed ID: 3609210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
